Načítá se...
Use of the Crohn’s disease activity index in clinical trials of biological agents
The Crohn’s disease activity index (CDAI) has been commonly used to assess the effects of treatment with different agents in Crohn’s disease (CD). However, these studies may be compromised, if the results compared to a placebo or standard therapy group (in the absence of a placebo) substantially dif...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The WJG Press and Baishideng
2008
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2725371/ https://ncbi.nlm.nih.gov/pubmed/18636655 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.14.4127 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|